Eckert & Ziegler acquires American cancer specialist
Eckert & Ziegler BEBIG s.a. is to acquire the prostate cancer implants business of the American company Biocompatibles Inc. for $5 million. Biocompatibles Inc., a BTG International group company, is based in Connecticut and is the fourth largest provider of such products in the United States and generated sales of approximately €8 million in 2012. Biocompatibles Inc. had voluntarily suspended manufacture and delivery of its products in May 2013 following claims of shortcomings in its documentation of the manufacturing process by the U.S. Food and Drug Administration.
Eckert & Ziegler is now acquiring the division and hopes to remedy these shortcomings quickly so that it can resume delivery. The management expects to be able to win back customers who have migrated elsewhere as Biocompatibles has developed several innovations that improve the use of implants and has patented these unique solutions. By purchasing the division, Eckert & Ziegler will be able to offer these enhanced solutions to its European customers too. In the medium term, the Eckert & Ziegler Group intends to use Biocompatibles as an American distribution platform for its entire range of tumor irradiation products.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.